台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    77.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.65%
  • 成交量
    191
  • 產業
    上櫃 生技醫療類股▲0.61%
  • 118人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-玉山-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1300.000.275.5076.10-0.2194-0.08%
2024/12/2600.00176.5077.80-1183-0.55%
2024/12/1300.00173.4073.70-1162-0.61%
2024/12/09175.90175.9075.4001490.00%
2024/11/29377.00377.0077.0001330.00%
2024/11/2100.00178.0079.40-1108-0.92%
2024/11/2000.00176.5076.80-1101-0.99%
2024/11/14176.1000.0075.8011040.95%
2024/11/11177.0000.0076.7011080.92%
2024/11/08179.20179.9079.3001070.00%
2024/11/04177.0000.0076.6011100.91%
2024/10/2800.00278.4078.00-2126-1.58%
2024/10/2400.00178.3078.80-1135-0.74%
2024/10/22176.8000.0076.8011370.73%
2024/09/26282.9000.0081.9021871.07%
2024/08/2800.00280.3082.30-2296-0.68%
2024/08/1300.00180.0079.00-1297-0.34%
2024/07/2200.000.381.6081.60-0.3287-0.09%
2024/07/1800.001.283.4583.20-1.2280-0.41%
2024/06/27183.5000.0083.5012690.37%
2024/06/2600.000.183.9084.30-0.1266-0.04%
2024/06/25286.1000.0083.5022600.77%
2024/06/24194.0000.0089.2012380.42%
2024/06/1400.00296.5097.10-2217-0.92%
2024/06/0700.000.398.5099.60-0.3220-0.11%
2024/05/29295.2000.0095.3022390.84%
2024/05/1700.00195.0095.00-1286-0.35%
2024/05/1600.000.393.9094.00-0.3317-0.09%
2024/05/1000.00294.4094.30-2324-0.62%
2024/05/02196.0000.0096.0013190.31%
2024/04/2300.000.294.4094.10-0.2327-0.06%
2024/04/1600.00696.0596.80-6334-1.80%
2024/04/150.198.0000.0098.300.13310.02%
2024/04/12099.4000.0099.4003310.00%
2024/04/0800.001100.0099.60-1329-0.30%
2024/04/0200.00199.3098.00-1330-0.30%
2024/03/28198.2000.0097.8013430.29%
2024/03/0800.00695.3895.70-6372-1.61%
2024/03/07199.6000.0099.0013620.28%
2024/03/052100.0000.00100.5023550.56%
2024/03/0400.002103.00102.00-2349-0.57%
2024/02/261104.5000.00104.5013390.29%
2024/02/2300.001102.00102.00-1345-0.29%
2024/02/212105.0000.00104.0023480.57%
2024/02/201106.0000.00106.0013400.29%
2024/02/1900.001.5103.85107.00-1.5322-0.48%
2024/02/0500.00295.0094.40-2282-0.71%
逸達前列腺癌新劑型新藥 確立美國藥證審查完成目標日Anue鉅亨-15天前
逸達營收/去年4.2億、年增115% 今年拚歐、美、中新藥藥證UDN聯合新聞網-20天前
逸達進軍歐盟 首批前列腺癌新劑型新藥正式出貨Anue鉅亨-2024/12/18
逸達 相關文章
逸達 相關影音